Equities By Region UK Europe Asia Pharmaceuticals & Health

Shire share price: EU clears Takeda’s acquisition of group

Share this article!

The European Commission has granted conditional clearance to Takeda’s acquisition of Shire (LON:SHP), the companies have said. The move came after the Japanese group recently proposed the sale of the UK group’s prospective treatment for inflammatory bowel disease in an effort to secure the approval.

Shire’s share price has climbed higher in today’s session, having added 0.48 percent to 4,622.00p as of 14:31 GMT. The stock is outperforming the broader UK market, with the benchmark FTSE 100 index currently standing 0.78 percent lower at 6,946.26 points. The group’s shares have added more than 28 percent to their value over the past year, as compared with a near six-percent dip in the Footsie.

EU clears Takeda’s acquisition of Shire

Japan’s Takeda announced in a statement today that the European Commission had approved its proposed acquisition of Shire. The company noted that the approval is conditional on the companies fulfilling commitments given to the Commission, specifically, in relation to the future potential overlap in the area of inflammatory bowel diseases, with Shire and Takeda having committed to divest the UK group’s compound SHP647 and certain associated rights. 

“We are very pleased to have secured clearance from the European Commission, the final regulatory approval required to proceed with our acquisition of Shire,” Christophe Weber, President and Chief Executive Officer of Takeda, commented in the statement.

Advisory firms back $62-billion deal

The deal remains contingent on shareholder approval, and Reuters reported today that Institutional Shareholder Services and Glass Lewis had both recommended that Takeda shareholders vote for the acquisition at an investor meeting scheduled for December 5. The news marks a boost for the Japanese group which has faced a campaign by a group of retail investors looking to derail the takeover.

As of 15:00 GMT, Tuesday, 20 November, Shire PLC share price is 4,640.50p.

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.